Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma. [electronic resource]
- Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2000
- 191-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1120-8694
10.1046/j.1442-2050.2000.00110.x doi
Adult Aged Antineoplastic Combined Chemotherapy Protocols--therapeutic use Carcinoma, Squamous Cell--drug therapy Chemotherapy, Adjuvant Cisplatin--therapeutic use Esophageal Neoplasms--drug therapy Esophagectomy Female Fluorouracil--therapeutic use Humans Immunohistochemistry Lymph Node Excision Male Middle Aged Prognosis Proto-Oncogene Proteins c-bcl-2--metabolism Tumor Suppressor Protein p53--metabolism